However, in HFD-fed mice, neither OEA signalling within the intestine (via G-coupled protein receptor 119) nor within the liver (via PPAR or CD36) was necessary for the effect of VSG on weight loss and/or glucose homeostasis 41
For pharma stakeholders, the message is clear: the obesity and diabetes drug market is not just a therapeutic opportunity, but a strategic growth engine for the next decade.
Key points to follow: Follow the IMP label or trial protocol for the exact storage temperature and BUD do not assume a temperature range or time window If no BUD is stated , treat the preparation as single-use and administer immediately after reconstitution
Well walk you through the steps, help you get started with LillyDirect or NovaCare, and ensure you're supported every step of the way
L., Strojek, K., Tabak, ., & Jacob, S